| 摘要 |
PROBLEM TO BE SOLVED: To provide a method for risk stratification for acute coronary syndrome (ACS), in particular acute myocardial infarction (AMI) and angina pectoris (AP), wherein provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, is determined by an in-vitro diagnosis.SOLUTION: Provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, which has high sensitivity and specificity for the diagnosis of acute coronary syndrome is determined by an in-vitro diagnosis. |
